Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Blueprint Medicines Corporation Stock Price (Quote) NASDAQ:BPMC
$100.15 ( -1.17% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $95.01 | $110.08 | Friday, 15th Oct 2021 BPMC stock ended at $100.15. This is 1.17% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 3.36% from a day low at $100.02 to a day high of $103.38. |
| 90 days | $79.08 | $110.08 | |
| 52 weeks | $79.08 | $125.61 |
Historical Blueprint Medicines Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $102.66 | $103.38 | $100.02 | $100.15 | 241 136 |
| 2021-10-14 | $99.66 | $103.31 | $99.66 | $101.34 | 198 533 |
| 2021-10-13 | $99.15 | $99.95 | $97.23 | $98.71 | 235 209 |
| 2021-10-12 | $99.30 | $101.11 | $98.62 | $98.75 | 260 992 |
| 2021-10-11 | $99.48 | $100.43 | $98.29 | $98.68 | 185 164 |
| 2021-10-08 | $98.30 | $100.90 | $98.00 | $100.09 | 229 067 |
| 2021-10-07 | $96.22 | $99.13 | $95.27 | $98.51 | 441 968 |
| 2021-10-06 | $95.63 | $97.74 | $95.01 | $96.29 | 193 133 |
| 2021-10-05 | $98.18 | $100.32 | $95.86 | $96.25 | 280 763 |
| 2021-10-04 | $101.63 | $101.63 | $96.87 | $97.99 | 357 171 |
| 2021-10-01 | $102.57 | $102.94 | $100.17 | $101.72 | 427 520 |
| 2021-09-30 | $104.33 | $104.73 | $102.64 | $102.81 | 303 303 |
| 2021-09-29 | $104.56 | $106.02 | $102.68 | $103.73 | 281 168 |
| 2021-09-28 | $105.03 | $106.29 | $102.17 | $103.81 | 504 060 |
| 2021-09-27 | $107.06 | $107.26 | $105.72 | $106.36 | 210 531 |
| 2021-09-24 | $108.89 | $109.05 | $106.45 | $106.61 | 188 809 |
| 2021-09-23 | $109.16 | $110.08 | $107.61 | $109.47 | 380 815 |
| 2021-09-22 | $107.81 | $109.80 | $107.08 | $109.19 | 315 209 |
| 2021-09-21 | $105.75 | $108.62 | $105.29 | $107.61 | 372 658 |
| 2021-09-20 | $104.19 | $105.52 | $104.19 | $105.18 | 321 223 |
| 2021-09-17 | $103.64 | $106.22 | $102.52 | $106.00 | 818 186 |
| 2021-09-16 | $103.97 | $103.97 | $101.18 | $102.96 | 466 895 |
| 2021-09-15 | $100.54 | $103.84 | $99.20 | $103.73 | 388 438 |
| 2021-09-14 | $99.96 | $101.25 | $98.83 | $100.03 | 270 568 |
| 2021-09-13 | $98.70 | $101.76 | $97.46 | $99.51 | 583 955 |
| 2021-09-10 | $94.46 | $98.97 | $93.28 | $98.69 | 428 881 |
| 2021-09-09 | $95.21 | $96.56 | $94.10 | $94.43 | 281 023 |
| 2021-09-08 | $95.31 | $96.70 | $93.82 | $95.30 | 278 316 |
| 2021-09-07 | $97.35 | $98.48 | $95.08 | $95.70 | 231 871 |
| 2021-09-03 | $98.21 | $99.23 | $97.58 | $97.81 | 413 930 |
| 2021-09-02 | $96.69 | $98.62 | $95.25 | $98.60 | 340 233 |
| 2021-09-01 | $93.75 | $96.28 | $93.75 | $96.13 | 794 255 |
| 2021-08-31 | $94.42 | $95.19 | $92.37 | $93.27 | 538 594 |
| 2021-08-30 | $94.27 | $95.16 | $93.27 | $94.05 | 471 891 |
| 2021-08-27 | $93.24 | $95.97 | $92.60 | $93.77 | 306 639 |
| 2021-08-26 | $94.31 | $94.76 | $92.12 | $92.66 | 272 778 |
| 2021-08-25 | $94.86 | $95.17 | $93.00 | $93.85 | 361 858 |
| 2021-08-24 | $96.58 | $96.97 | $93.36 | $94.81 | 246 097 |
| 2021-08-23 | $94.71 | $96.79 | $94.71 | $96.13 | 472 538 |
| 2021-08-20 | $91.66 | $94.78 | $91.66 | $93.83 | 297 876 |
| 2021-08-19 | $93.06 | $93.65 | $91.69 | $91.84 | 273 076 |
| 2021-08-18 | $94.89 | $95.24 | $93.24 | $93.45 | 238 703 |
| 2021-08-17 | $91.93 | $94.42 | $91.20 | $94.25 | 235 001 |
| 2021-08-16 | $93.99 | $93.99 | $92.21 | $92.97 | 253 800 |
| 2021-08-13 | $95.22 | $95.43 | $94.11 | $94.52 | 283 151 |
| 2021-08-12 | $95.57 | $95.76 | $93.05 | $94.68 | 266 538 |
| 2021-08-11 | $94.48 | $95.31 | $92.63 | $95.22 | 232 596 |
| 2021-08-10 | $94.82 | $94.82 | $92.14 | $94.48 | 373 753 |
| 2021-08-09 | $95.16 | $96.50 | $93.91 | $94.50 | 540 525 |
| 2021-08-06 | $89.67 | $95.67 | $88.87 | $95.49 | 723 881 |
Blueprint Medicines Corporation, a biopharmaceutical company, develops drugs of small molecule kinase inhibitors that target genomic drivers in various cancers and rare genetic diseases. Its lead drug candidates include BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants for patients with systemic mastocytosis, a myeloproliferative disorder of the mast cells, and defined subsets of patie... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
